Review of Pharmacokinetic, Pharmacodynamic and Clinical Studies with a Modern Combination of Amoxicillin/Sulbactam
Authors:
- J. SoutricJSJ. Soutric
- C. BantarCBC. Bantar
- N. CarusoNCN. Caruso
- R. HeguilénRHR. Heguilén
- J.M. Casellas Jr.JJJ.M. Casellas Jr.
- J.M. CasellasJCJ.M. Casellas
- A. FarinatiAFA. Farinati
- A. JasovichAJA. Jasovich
- H. ArenosoHAH. Arenoso
- M. RodriguezMRM. Rodriguez
- 1 June 2006
- journal article
- review article
- Published by S. Karger AG in Chemotherapy
- Vol. 52 (4) , 200-204
Abstract
Amoxicillin/sulbactam is a modern antimicrobial combination. This combination proved to be useful for the treatment of several infections caused by different microorganisms, mainly with the β-lactamase-producing species. In this review we present the most relevant pharmacokinetic, pharmacodynamic and clinical information associated with its use.Keywords
This publication has 8 references indexed in Scilit:
- Amoxicillin-sulbactam versus amoxicillin-clavulanic acid for the treatment of non-recurrent-acute otitis media in Argentinean childrenInternational Journal of Pediatric Otorhinolaryngology, 2005
- Acute Community-Acquired Pneumonia in Adults: Guidelines for Initial Antimicrobial Therapy Based on Local Evidence from a South American Working Group (ConsenSur)Journal of Chemotherapy, 2002
- Efficacy of Amoxicillin-Sulbactam, Given Twice-a-Day, for the Treatment of Community-Acquired Pneumonia: A Clinical Trial Based on a Pharmacodynamic ModelJournal of Chemotherapy, 2002
- Antimicrobial Resistance in Respiratory Tract Pathogens: Results of an International Surveillance StudyChemotherapy, 2000
- Treatment of Community-Acquired PneumoniaChemotherapy, 2000
- A Pharmacodynamic Model to Support a 12-Hour Dosing Interval for Amoxicillin/Sulbactam, a Novel Oral Combination, in the Treatment of Community-Acquired Lower Respiratory Tract InfectionsJournal of Chemotherapy, 2000
- Pharmacokinetics and Pharmacodynamics of Amoxicillin-Sulbactam, a Novel Aminopenicillin–β-Lactamase Inhibitor Combination, against Escherichia coliAntimicrobial Agents and Chemotherapy, 1999
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998